ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Biogen Inc

Biogen Inc (IDP)

147.80
1.60
(1.09%)
Closed 05 January 8:00AM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
147.80
Bid
147.25
Offer
148.25
Volume
295
145.45 Day's Range 148.50
0.00 52 Week Range 0.00
Market Cap
Previous Close
146.20
Open
146.05
Last Trade
1
@
148.3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
19.10
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker IDP. The last closing price for Biogen was 146.20 €. Over the last year, Biogen shares have traded in a share price range of 0.00 € to 0.00 €.

Biogen currently has 145,719,340 shares in issue. The market capitalisation of Biogen is 21.30 € billion. Biogen has a price to earnings ratio (PE ratio) of 19.10.

IDP Latest News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

IDP - Frequently Asked Questions (FAQ)

What is the current Biogen share price?
The current share price of Biogen is 147.80 €
How many Biogen shares are in issue?
Biogen has 145,719,340 shares in issue
What is the market cap of Biogen?
The market capitalisation of Biogen is EUR 21.3B
What is the 1 year trading range for Biogen share price?
Biogen has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Biogen?
The price to earnings ratio of Biogen is 19.1
What is the cash to sales ratio of Biogen?
The cash to sales ratio of Biogen is 2.26
What is the reporting currency for Biogen?
Biogen reports financial results in USD
What is the latest annual turnover for Biogen?
The latest annual turnover of Biogen is USD 9.84B
What is the latest annual profit for Biogen?
The latest annual profit of Biogen is USD 1.16B
What is the registered address of Biogen?
The registered address for Biogen is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Biogen website address?
The website address for Biogen is www.biogen.com
Which industry sector does Biogen operate in?
Biogen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0S6Cerence Inc
18.972 €
(145.34%)
89.94k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
7DBDiamondback Energy Inc
9.7176 €
(-94.02%)
800
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discussion

View Full Feed
demonsmith demonsmith 4 minutes ago
I put buy order in today for 20 mil more shares soon as it trades my order will fill
TWOH
theorysuit theorysuit 5 minutes ago
NWBO provides the ammunition to be shorted by their OTC loan sharks. Risk free Loans.....I know pumpers like to claim this is how all non-rev bios work. No, they get financed by funds and don't go to OTC loan sharks and they don't have 1.3B plus shares oustanding. This is what happens when yo
NWBO
TenKay TenKay 5 minutes ago
The trend has been down since the beginning of January and you think a day or even two above the recent typical volume suddenly changes that?

…ummm…ok.
HMBL
Corey3055 Corey3055 6 minutes ago
Yeah, I hear 2 different things. One avenue is it will be a immediate merger after Pink and then the other is once they are Pink they need to do an Audit before they merge. The later one really pisses me off, if true. Lol
EEGI
Archie Lopp Archie Lopp 7 minutes ago
For sure , I hate paid bashers.
RNVA
Ooou812 Ooou812 7 minutes ago
Market Outlook HIVE
We may be at a market bottom or at the start of a reaction rally. The bulls have strong evidence on their side and this evidence prompts us to make a bullish bet. Today’s candlestick has a white body and its close is above the confirmation level. The bullish pattern that w
HIVE
DCBill DCBill 7 minutes ago
Both were delisted from the major systems shortly after Paulson's 2008 "Conservatorship" capert; since they still were/are public companies (recently trading below a dollar per common share), they are traded on the "pink sheets," where low-dollar stock corporations are traded.
If they get re
FNMA
100lbStriper 100lbStriper 7 minutes ago
yes, the pendulum not only needs blood to spill on this sway, but to sever something as well. hoping the money comes soon.
NLST
jimr1717 jimr1717 7 minutes ago
Now this is incredible. Do you have a link to your personal page with much greater detail about this possible massive revenue producing break through?
SINT
nowwhat2 nowwhat2 8 minutes ago
re : Los Gambinos


https://investorshub.advfn.com/uimage/uploads/2025/1/4/mqnxzxrp_!_4_3m_GAMBINOS.jpg






https://investorshub.advfn.com/uimage/uploads/2025/1/4/dgdzbxrp_!_4_45d_9am_w_2_6pm__inev.jpg


Pe
XRPUSD
theorysuit theorysuit 9 minutes ago
Can anyone just post factual information on where things are at up to now and timelines etc.


You got to be joking right? Timelines? TImelines and NWBO are like oil and water.
NWBO
tdbowieknife tdbowieknife 10 minutes ago
That sounds like something Marc would say....

lol...

And I don't post non-sense. It made perfect sense as someone just got 30 million shares moved from restricted to un-restricted. And that was a fact.

.


Buyer Beware
P
IFUS
dstock07734 dstock07734 10 minutes ago
Most likely by now, at least over one thousand patients have received DCVax-L treatment. You do know that GBM is the most difficult cancer, don't you? Avastin didn't extend OS on rGBM patients. But it shrinks tumor and extends PFS. I would say any RA with common sense including FDA would grant the a
NWBO
Gmenfan Gmenfan 11 minutes ago
Can't imagine why!!!
fwb fwb 11 minutes ago
Good Luck......
I'll stick with PLTR and NVDA
NVDA PLTR
ChannelTrader ChannelTrader 11 minutes ago
One world agenda, not good, Bob, not good at all. Next, it'll be Mexico
Mr. Wonderful' Kevin O'Leary Promotes Trump's Suggestion of Canada Merging With the US -
theusmilitarynews.com
TenKay TenKay 12 minutes ago
For some reason a bunch of iHub pumpers thought I was female either because someone thought this was me:

https://stocktwits.com/gracie28

And others thought I was another alias of Janice.

Alas I am not.
HMBL
Gmenfan Gmenfan 12 minutes ago
Best laugh I had today!
MoneyMike1 MoneyMike1 13 minutes ago
New head of Cenagas! Bye bye crooked a$$ Alipi. Now they should be able to get something done with all the momentum of new people everywhere and articles about natural gas storage dropping every 5 minutes.

Cuitláhuac García will be director of Cenagas, announces Sheinbaum
MRGE
RKMKE RKMKE 13 minutes ago
I have feeling it will be full of forward looking statements and past progress which cannot be verifiable by retail...

In my opinion
WDLF
NoMoDo NoMoDo 13 minutes ago
Wow. Good find on twitter/x... thought I would repost HMBL news since it was removed:
https://x.com/shopmarkey/status/1875606147610050766?s=46&t=FWyCU7KfIDokGToTtqinIg
HMBL
skitahoe skitahoe 14 minutes ago
I certainly don't know what the company will be revealing at JP Morgan or other upcoming conferences, both technical and Institutional. The question in my mind is, will the company based on the strength of the new material being revealed choose to apply to other regulators, especially to the FDA, o
AVXL
Fly686 Fly686 14 minutes ago
Here is something everyone can chew on.Back in Dec 2023 lvvv finished a harvest of 40k wet flower.There was a bust of an illegal farm with 8k pounds of weed worth 7million. Do the math, Someone is making a lot of money and us share holders don’t get sh…..t.
LVVV

Your Recent History

Delayed Upgrade Clock